SENSEX 83,010.62

+ 1,113.83

NIFTY 25,308.75

+ 336.85

CRUDEOIL 5,604.00

-442.00

GOLD 97,267.00

-2,121.00

SILVER 105,510.00

-1,249.00

SENSEX 83,010.62

+ 1,113.83

NIFTY 25,308.75

+ 336.85

NIFTY 25,308.75

+ 336.85

CRUDEOIL 5,604.00

-442.00

CRUDEOIL 5,604.00

-442.00

GOLD 97,267.00

-2,121.00

Ajanta Pharma Ltd News Today

BSE - 532331
NSE - AJANTPHARM
ISIN - INE031B01049

Stocks
Q4 Results Highlights: Adani Power Q4 profit down, IOC, Vedanta Q4 profit rises, CRISIL profit up 16%, Ujjivan SFB profit slumps, Bajaj Finance, Bajaj Finserv, Trent slumps post Q4 results, Vishal Mega Mart jumps 10%
Q4 Results Today Highlights April 30, 2025: Get the latest Q4 2025 earnings highlights for Adani Power, Indian Oil Corporation, Varun Beverages, Exide Industries, Vedanta, INDUS TOWERS, Jindal Steel & Power, Coromandel International, JSW Infrastructure, Phoenix Mills, Federal Bank, Ajanta Pharma, CRISIL, Sona BLW Precision Forgings, Bandhan Bank, Sundram Fasteners, Godrej Agrovet, KSB, Ujjivan Small Finance Bank and more here.
Stocks
Indian pharma stocks crack 4% amid Trump’s unprecedented tariff threat
Personal Finance
Fundamental investing: The premium in stocks for being consistent
Stocks
Q3 Results Highlights 30 Jan: Adani Ports & GAIL profit rises, BEL stock lead gains, Hitachi Energy shares shine, Tata Motors ends 7% lower post Q3 results
Q3 Results Today Highlights January 30, 2025: Find all the latest Q3 results 2025 updates for Adani Enterprises, Adani Ports and Special Economic Zone, Dabur India, Bank of Baroda, Larsen & Toubro (L&T), Bajaj Finserv, Kalyan Jewellers, Astral, Bharat Electronics, Timex Group, Greenlam, Waaree Energies, Jindal Steel & Power, RCC Cements, Shree Cements, Coromandel Agro Products & Oils and a few more companies to announce their Q3 results today.
Technical Analysis
Stock to buy today: Ajanta Pharma (₹2,291.05)
Video
Today’s Stock Recommendation: July 23, 2024
Stock Fundamentals
Ajanta Pharma buyback: Should investors tender their shares?
Stocks
Sensex, Nifty open higher; Bajaj Finance surges over 6%
Stocks
Ajanta Pharma’s shares surge by 9.55%
Stock Fundamentals
Ajanta Pharma: Here is why the stock can be accumulated on dips
News Analysis
Ajanta Pharma Buyback: Should you tender the stock?
Markets
Broker's call: Ajanta Pharma (Buy)

Sign into Unlock benefits!

Access 10 free stories per month
Access to comment on every story
Sign up/Manage to our newsletters
Get notified by email for early preview to new features, discounts & offers

SENSEX 83,010.62

NIFTY 25,308.75

CRUDEOIL 5,604.00

GOLD 97,267.00

SILVER 105,510.00

SENSEX 83,010.62

NIFTY 25,308.75

NIFTY 25,308.75

CRUDEOIL 5,604.00

CRUDEOIL 5,604.00

GOLD 97,267.00

STOCKS

STORIES

STOCKS

STORIES

STOCKS

STORIES

Ajanta Pharma Ltd News Today

Q4 Results Highlights: Adani Power Q4 profit down, IOC, Vedanta Q4 profit rises, CRISIL profit up 16%, Ujjivan SFB profit slumps, Bajaj Finance, Bajaj Finserv, Trent slumps post Q4 results, Vishal Mega Mart jumps 10%

Indian pharma stocks crack 4% amid Trump’s unprecedented tariff threat

Fundamental investing: The premium in stocks for being consistent

Q3 Results Highlights 30 Jan: Adani Ports & GAIL profit rises, BEL stock lead gains, Hitachi Energy shares shine, Tata Motors ends 7% lower post Q3 results

Stock to buy today: Ajanta Pharma (₹2,291.05)

Today’s Stock Recommendation: July 23, 2024

Ajanta Pharma buyback: Should investors tender their shares?

Sensex, Nifty open higher; Bajaj Finance surges over 6%

Ajanta Pharma’s shares surge by 9.55%

Ajanta Pharma: Here is why the stock can be accumulated on dips

Ajanta Pharma Buyback: Should you tender the stock?

Broker's call: Ajanta Pharma (Buy)